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• Published literature on suicidal ideation among women with breast cancer undergoing 
mastectomy and reconstruction is limited. 
• Psychological distress was assessed in a cohort of over 1,900 women with breast cancer 
enrolled in a prospective, multicenter study focusing on reconstruction outcomes. 
• Nearly one in six women reported moderate-to-severe levels of anxiety and depression. 
• Fourteen women reported significant suicidal ideation, prompting the development of a 
response system to enable triage to appropriate mental health services. 








Emotional and social adaptation is a central challenge for women with recently diagnosed breast 
cancer [1]. Prevalence rates for anxiety and depressive disorders among a heterogeneous sample 
of cancer patients are estimated to range from 10 to 40% [2,3], and women with newly diagnosed 
breast cancer demonstrate comparable rates of affective distress [4]. As a result, breast 
reconstruction outcome studies routinely assess psychological variables and their influence on 
various patient-specific outcomes such as aesthetic satisfaction and functional status. While these 
studies typically include measures of preoperative depression and anxiety as possible predictors 
of clinical outcomes, relatively little attention has been paid to the identification of suicidal 
ideation (SI) in this cohort. This may seem surprising given evidence that depression is highly 
prevalent among cancer patients and, when increasingly severe, presents a primary risk for SI 
and intention [5].  While numerous  studies describe the incidence of suicide among cancer 
patients in general [6], and women with breast cancer more specifically [7], there is sparse 
information on the prevalence of suicidal ideation among these populations. The assessment of 
SI in breast cancer patients presenting for reconstruction is in line with the American College of 
Surgeons (ACS) Commission on Cancer guidelines for distress screening of all cancer patients 
by 2015 [8]. 
 
We examined the prevalence of preoperative anxiety and depression among women enrolled in 
an ongoing prospective study of post-mastectomy breast reconstruction procedure outcomes. The 
prevalence of moderate-to-severe SI challenged the study team to devise an identification and 
response system to intervene with potential at-risk patients and triage them to appropriate mental 
health attention. We describe this system and propose its consideration for future surgical 




Patients were recruited as part of the Mastectomy Reconstruction Outcomes Consortium Study, a 
five-year prospective, multicenter cohort study comparing long-term outcomes of common post-
mastectomy breast reconstruction procedures. Eligible subjects included women ≥18 years 
undergoing first-time unilateral or bilateral breast reconstruction. Only women with breast cancer 
undergoing immediate reconstruction were included in this analysis. Appropriate approval from 
the Institutional Review Board (IRB) at each participating site was obtained. 
 
Data Collection 
Prior to surgery, patients completed a battery of patient-reported outcome questionnaires 
soliciting information regarding sociodemographic status, general well-being, treatment 
satisfaction, pain, and psychosocial status.  All data are collected via Velos (Velos Inc., Fremont, 
CA), a web-based clinical trial management system. For the current study, we specifically 
analyzed preoperative data from two measures of anxiety and depressive symptoms.  





Anxiety was evaluated by the Generalized Anxiety Disorder (GAD-7) scale [9], a seven-item 
self-report inventory that asks respondents to report the frequency of anxiety symptoms over the 
previous two weeks from “none” (0 score) to “daily” (score of 3). A patient’s level of anxiety is 
scaled as none/minimal (0-4), mild (5-9), moderate (10-14), or severe (15-21). A GAD-7 score of 
≥10 has a sensitivity of 89% and a specificity of 82% for a diagnosis of generalized anxiety 
disorder.  
 
Depressive symptoms were assessed using the Patient Health Questionnaire (PHQ-9) [7], a nine-
item self-report inventory that quantifies the frequency of depressive symptoms over the 
previous two weeks. Depression levels are interpreted as none/minimal (0-4), mild (5-9), 
moderate (10-14), moderately severe (15-21), or severe (20-27). PHQ scores of ≥10 have a 
sensitivity of 88% and specificity of 88% for a diagnosis of major depression. Notably, the last 
item on the PHQ-9 asks patients to report the frequency of suicidal thoughts and has been found 
to be significantly associated with suicidality in cancer patients [11]. Significant SI for this study 
was defined as a score of 2 or 3 reflecting thoughts of suicide occurring more than half the days 
of the week or every day.  
 
Results 
Of a total subject pool of 2378, 2144 (90.2%) women had a diagnosis of breast cancer.  
Immediate post-mastectomy reconstruction was performed in 1922 (89.6%), with 54.9% 
undergoing bilateral procedures. The majority underwent implant-based reconstruction (71.6%) 
compared to autologous tissue (25.6%). Among the potential study sample, 1912 (99.5%) 
women completed the GAD-7 and 1921 (99.9%) completed the PHQ-9 preoperatively. The mean 
age of women completing the questionnaires was 49.4 ± 10.0 years. 
 
A total of 337 (17.6%) patients reported moderate or severe anxiety, while 314 (16.3%) indicated 
moderate or severe depression. Of greatest concern, 14 (0.7%) patients reported significant SI. 
Two of these women reported daily thoughts of suicide. 
 
Discussion 
Our findings replicate previous investigations demonstrating relatively higher rates of anxiety 
and depressive symptoms among women with breast cancer [2]. Over 16% of our sample 
reported moderate-to-severe anxiety and depressive symptoms, suggesting that these patients 
suffered potentially clinically significant emotional distress. Assessing for psychological distress 
may be particularly relevant for the cohort of women seeking immediate reconstruction as they 
may manifest more acute and severe depressive symptoms when compared to women who 
choose mastectomy alone or delayed reconstruction [12]. 
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The finding of greatest concern was that 14 patients reported suicidal thoughts more than half the 
days of the week, with two disclosing daily thoughts of suicide. However, the prevalence of SI in 
our cohort was low at 0.7% compared to a prior study using the PHQ-9 among a sample of 
cancer patients that found 7.8% of responders reporting significant SI [13]. Among the general 
population, SI prevalance ranges from 1-20% [14]. Obviously, the report of SI on a self-report 
survey is not a clinical determination of individual suicidal intention and risk, which requires a 
careful psychiatric inquiry based on known parameters of suicidality. Nonetheless, suicide risk is 
an important clinical concern for comprehensive cancer patient management, given its potential 
lethality and prevalence [5]. Several recent reports have raised concern for suicidality 
specifically among women with breast cancer or a history of breast surgery. For example, 
Riihimäki et al. observed that suicide was the second leading cause of non-cancer death among a 
cohort of women with a history of breast cancer [15]. Taken together, these preliminary findings 
suggest that while the rate of suicide among breast cancer patients remains quite low, suicidality 
should be a concern for all practitioners caring for this population [5].  
 
Although our study is observational rather than interventional in nature, we recognized a 
responsibility to protect women deemed at risk based on their reported experience of frequent 
suicidal thoughts. Following IRB approval, a response system was developed to address the need 
for rapid assessment of patients with serious SI (Figure 1). The study’s web-based data collection 
system, Velos, queries the database every 12 hours for newly-entered responses to question #9 
on the PHQ-9 equivalent to significant suicidal thoughts (a score of 2 or 3). When such an entry 
is detected, an automatic email alert is sent to the study Principal Investigators (PIs), the site PI 
overseeing the study at the patient’s treatment facility, and the MROC study manager. Upon 
receipt of the alert, the patient is contacted by a qualified member of her healthcare team to 
assess safety and provide psychological support. Although contact procedures vary by site, a 
clinician with a mental health background, such as an oncology nurse or social worker, in 
addition to the site PI, is usually identified to contact the patient. Each site has developed its own 
process to facilitate a referral to social work or psychiatry, either urgently or expediently, 
depending on the perceived severity of the suicide risk. It is ultimately the responsibility of the 
treatment site PI to ensure the patient is contacted. Since the system is automatic, it is in 
operation 24 hours a day. Most importantly, it effectively enables the study team to intervene in a 
timely fashion when patients report frequent suicidal thoughts. To date, the majority of patients 
have been contacted within 24 hours, with delays most often a result of patients traveling out of 
town or not answering their telephone. 
 
Health care practitioners frequently fail to recognize distress in the cancer patient population [5]. 
It is likely that reconstruction outcome studies involving breast cancer patients, even those that 
obtain preoperative patient distress measures, are similarly unaware of clinically significant 
distress among enrolled subjects. In these studies, baseline psychological measures are typically 
relegated to a data bank and become operative only once statistical analysis is undertaken to 
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evaluate surgical outcomes. As a result, relevant clinical information that could be potentially 
crucial for intervening with appropriate mental health services is obscured. While it is unrealistic 
to expect surgeons to become experts in suicide assessment and intervention, our study illustrates 
how an automated identification and triage system can be established to address psychological 
morbidity in cancer patients seeking surgical intervention. 
 
In conclusion, our findings support the new standards of the ACS Commission on Cancer 
requiring distress screening for all new cancer patients. The baseline questionnaires identified 
women who were troubled by recurrent and strong SI, which prompted the development of a 
response system to address these patients’ needs for expedited psychiatric intervention. Not only 
do our results demonstrate that approximately one-in-six breast cancer patients seeking 
reconstruction report moderate-to-high levels of distress, but that an automated response system 
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Figure 1. Response system developed to identify and contact at-risk patients. 
PI, principal investigator. 
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